Trial Profile

Assessment of Brain Tau Burden in Participants With Parkinson's Disease in the PPMI Study (PPMI Tau PET Imaging)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 25 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PI 2620 (Primary)
Indications Parkinson's disease
Focus Diagnostic use
Acronyms PPMI Study; PPMI Tau PET Imaging

Most Recent Events

20 Apr 2023 Status changed from recruiting to completed.
18 Sep 2022 Results by deriving data from NCT02095171, NCT03100149, NCT04777331 and PPMI; developing Roche Digital Health Technology Platform to assess Disease Severity and Progression in Individuals with Parkinsons Disease, presented at the 26th International Congress of Parkinson's Disease and Movement Disorders
02 Sep 2021 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com